<!– –>
Covid-19, a research by the Istituto Superiore di Sanità confirms that type I interferon can block the progression of the disease
A new weapon could arrive from Italy in the fight against Covid-19. Type I interferon (IFN), released by plasmacytoid dendritic cells (pDc) at the beginning of coronavirus infection, appears to elicit an immune response in the body that blocks the progression of the disease. The discovery comes from the joint work of a team of researchers (University of San Raffaele in Milan, Polyclinic of Tor Vergata, University of Padua, Metabolic Fitness Association) coordinated by the Istituto Superiore di Sanita ‘(ISS). The study published in Plos Pathogens analyzes precisely the mechanisms of innate immune responses in the pathogenesis of Covid-19.
Read Also
- Marseille: He comes out of the ophthalmologist blind after a routine appointment Nov 23, 2022
- Restore the light and protect the eye: named for the healing properties of tomatoes May 23, 2020
- These popular products many people eat wrong Jul 30, 2020
- Astrazeneca, first mix of antibodies prevents covid Aug 20, 2021
- Delta variant, Ricciardi: “Buca also double dose vaccine” Jul 15, 2021
- Crisis in Argentina due to the pandemic: the figures left by the worst month in the country | Video Jun 2, 2021
- Tumors, mutation count not affected organ: ok Aifa to agnostic therapy made in Italy Sep 14, 2021